Skip to content

Taking products from
concept to clinic

Start process development with regulatory
compliance and scalability in mind

Start a conversation

With our approach for process development you can tackle major pain points in the development of cell-based therapeutics by bringing quality, robustness and GMP compliance to discovery and preclinical stages.

Discover our expertise >

Benefits of Ncardia Services for Regenerative Medicine

Proven iPSC Experts

Pioneers in iPSC technology with extensive expertise in process development

Agile Risk Mitigation

A plan based on a decision tree map anticipating all possible scenarios

Focus on Clinical Success

Introduce scalability and GMP regulations at once

SOLUTIONS

What we can do for you

As an innovator in regenerative medicine, you are facing the challenges of blending reproducibility, scalability, GMP regulations and cost-effectiveness.

With the Ncardia approach for iPSC generation and process development you can rely on robustness and streamline your path to clinical manufacturing, by introducing scale and GMP readiness right at the beginning.

Our experts can transfer the process over to you or keep supporting you during clinical manufacturing by leveraging our state-of-the-art GMP facilities of our sister company Cellistic.

Start a conversation >

Leverage our expertise

We have developed differentiation procedures for a wide range of cell types derived from all three germinal layers. With our expertise, we can expedite your journey to achieving your desired cell type efficiently and effectively.

 

Click to discover our expertise

 

Jan 29_ Social Post (1)-1

ON-DEMAND WEBINAR: Learn more about our approach for process development

Your trusted partner to maximize success

Define your Needs

We sit together to understand your specifications and co-develop a plan

Plan the Process

We set a project plan with clear timelines and milestones matching your expectations

Execute and Report

Follow project progress with frequent and transparent communication

Plan for the Future

We deliver results and discuss how to support you in your next steps

 

Getting to your target cell type faster

We’re ready to help you develop successful processes that will move your cell-based therapies from concept to clinic. So let’s start with a conversation

Mariana Argenziano, PhD Associate Director, Manufacturing Technology
Mariana 2